Latest News about Ram Mukunda
Recent news which mentions Ram Mukunda
Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial
November 26, 2024
From Benzinga
From Benzinga
IGC Pharma Announces Q3 2024 Earnings: Strategic Patent Achievements Propel Forward Amid Losses
February 19, 2024
Tickers
IGC
From Benzinga
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
From Benzinga
IGC Q3 2023 Revenue Grows 133% YoY, What About Net Loss?
February 15, 2023
Tickers
IGC
From Benzinga
IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
January 04, 2023
Tickers
IGC
From Benzinga
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
December 01, 2022
Tickers
IGC
From Benzinga
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
November 02, 2022
Tickers
IGC
From Benzinga